| |
| Device | EPi-Sense Guided Coagulation System |
| Generic Name | Surgical cardiac ablation device, for treatment of atrial fibrillation |
| Applicant | AtriCure, Inc. 7555 Innovation Way West Chester, OH 45040 |
| PMA Number | P200002 |
| Date Received | 01/02/2020 |
| Decision Date | 04/28/2021 |
| Product Code |
OCM |
| Advisory Committee |
Cardiovascular |
| Clinical Trials | NCT01984346
|
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
Approval Order Statement Approval for the EPi-Sense Guided Coagulation System is intended for the treatment of symptomatic long-standing persistent atrial fibrillation (continuous atrial fibrillation greater than 12 months duration) when augmented in a hybrid procedure with an endocardial catheter listed in the instructions for use, in patients who are refractory or intolerant to at least one Class I and/or III antiarrhythmic drug (AAD); and, in whom the expected benefit from rhythm control outweighs the potential known risks associated with a hybrid procedure such as delayed post-procedure inflammatory pericardial effusions. |
| Post-Approval Study | Show Report Schedule and Study Progress |
| Supplements: |
S001 S002 S003 S004 S005 S006 S007 S008 S009 S010 S011 S012 S013 |